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Abstract
Background: Conventional vaccination programs using a single injection of a combined vaccine against porcine
circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae (MHYO) can promote a strong immune response that
reduces feed intake for 24 to 48 h post injection. Often such vaccines are given around the time of weaning during
a critical stress period in which feed intake is already compromised. Spray dried porcine plasma (SDPP) is a protein
source used in starter diets that increases post-weaning feed intake of pigs. The objectives of this study were to
determine the effects of a conventional vaccination program along with feeding SDPP in a starter diet on antibody
development and wean to finish performance of pigs.
Results: Pigs fed the starter diet with SDPP had improved body weight, average daily weight gain and average
daily feed intake during the initial 14 d after weaning along with improved feed efficiency during the initial 7 d
after weaning and these responses were independent of vaccination. Vaccination at 3 d after weaning had no
significant effect on performance during the initial 14 d after weaning. Cumulative mortality was reduced for pigs
fed the starter diet with SDPP, while vaccinated pigs had reduced mortality from d 48 to 145. Both vaccinated pigs
and those fed the starter diet with SDPP had heavier carcass weight. One pig per pen was challenged with PCV2 at
d 63. A higher percentage of vaccinated pigs were sero-positive for antibodies against PCV2 and MHYO at d 35, 63
and 78. Antibody values against PCV2 were higher for vaccinated pigs at d 35 and 63, but lower at d 146.
Percentage of positive samples for PCV2 genome in serum was reduced for vaccinated pigs at d 117 and 146.
Antibody values against MHYO were increased for vaccinated pigs at d 35, 63 and 78.
Conclusions: Vaccination supported a long term antibody response against PCV2 and a moderate but weaker
antibody response against MHYO for early finishing pigs challenged with PCV2. Using SDPP in the starter diet along
with vaccination supported the best long-term beneficial effects on survival to market and carcass weight.
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Background
Spray dried porcine plasma (SDPP) or spray dried bovine
plasma (SDBP) has been used in nursery pig diets due to
its documented beneficial effects on post-weaning growth,
feed intake, morbidity indices and survival [1, 2]. In past
studies, under field conditions, pigs suffering from porcine
circovirus type 2-systemic disease (PCV2-SD, formerly
known as post-weaning multi-systemic wasting syndrome)
had improved performance and survival when fed diets
containing SDPP [3, 4]. PCV2 is the essential causative
agent of PCV2-SD, a multifactorial disease with a severe
economic impact worldwide. PCV2-SD is character-
ized by wasting, decreased weight gain, lymphadenop-
athy and dyspnea, affecting mainly pigs from 6 weeks
of age to market [5].
Mycoplasma hyopneumoniae (MHYO) is the main etio-
logical agent of enzootic pneumonia, a chronic respiratory
disease that affects mainly growing and finishing pigs.
MHYO and PCV2 are potential etiological contributors of
the porcine respiratory disease complex, which involves
bacterial as well as viral agents [6].
Experimental co-infection with MHYO and PCV2
resulted in a more severe clinical disease in growing
[7, 8] and adult [9] animals, although not always [10].
In all cases, PCV2 and MHYO vaccines have demon-
strated good results in eliciting antibody responses,
reduction of clinical signs and better productive out-
come [11–13]. In general, manufacturers recommend
the application of these vaccines around the time of
weaning.
However, pigs at weaning are subjected to complex
changes that can affect pig adaptation and growth. Vac-
cination against PCV2 and MHYO at weaning may
result in a transitory reduced feed intake and growth
rate [14–16]. For such a reason, products containing
spray dried plasma proteins and digestible energy given
in drinking water to weaned pigs have been used to
overcome the undesirable effects on growth performance
after injection with a PCV2/MHYO vaccine [15]. There
is growing evidence in pigs and other species that nutri-
tion before and after weaning can have long-term effects
on gut, microbiota interaction and immune development
[17]. Therefore, for the present study our objectives were
to determine the effects of SDPP in a starter diet fed to
pigs injected at 3 d after weaning with a single combined
vaccine against PCV2 and MHYO on wean to finish per-
formance, carcass parameters, and detection of pathogen
genome and antibody development against PCV2 and
MHYO.
Results
Treatment groups consisted of vaccinated (V) or saline
(S) injected pigs on d 3 after weaning, which were fed
starter diets with (P) or without (C) SDPP for the initial
14 d post-weaning. Pigs were assigned to 4 treatment
groups (1 VC, 2 VP, 3 SC, 4 SP) with a 2 × 2 factorial
arrangement of treatments to determine the effects on
wean to finish performance and carcass results and sero-
logical results over various time periods. Three orthog-
onal treatment comparisons were used to test for the
main effects of vaccination (vaccine vs saline injected
pigs; treatment groups 1 VC + 2 VP vs treatment groups
3 SC + 4 SP), starter diet (pigs fed 0 % vs 6 % SDPP in
starter diets; treatment groups 1 VC + 3 SC vs treatment
groups 2 VP + 4 SP), and the interaction of the main
effects of vaccination and starter diet (treatment groups
1 VC + 4 SP vs treatment groups 2 VP + 3 SC).
Nursery performance results
Average pen performance variables by treatment group and
periods of the experiment while pigs were housed at the
Institut de Recerca i Tecnologia Agroalimentàries (IRTA)
nursery facilities are presented in Table 1. The treatment
comparison for the main effect of starter diet indicated that
average daily weight gain (ADG) was higher for pigs fed
starter diet with SDPP during d 0–7 and 0–14 post-wean-
ing. Average daily feed intake (ADFI) was higher for
pigs fed starter diet with SDPP during d 0–7, 7–14
and 0–14. Feed efficiency (GF) was improved for pigs
fed starter diet with SDPP during d 0–7; but GF was
reduced during d 7–14. Treatment comparisons for
the main effect of vaccination and the interaction of
vaccination and starter diet were not significant for
ADG, ADFI or GF during the initial 14 d after wean-
ing or during any other time periods while pigs were
housed in nursery facilities. After d 14 when all pigs
were fed a common diet to the end of the nursery
phase (d 14–48) and for the entire nursery period (d
0–48), there were no significant effects on ADG,
ADFI or GF due to treatment comparisons for the
main effect of starter diet, vaccination or interaction
of starter diet by vaccination.
Mortality and morbidity
Mortality rate of pigs (Table 2) during the initial 14 d
after weaning was not significant for any of the treat-
ment comparisons. During d 14–48 and 0–48, mortality
rate was reduced for groups of pigs fed starter diet with
SDPP. During d 48–145, vaccinated pigs had reduced
mortality rate compared to non-vaccinated groups. Over
the entire wean to finish period (d 0–145), mortality rate
was reduced for groups of pigs fed the starter diet with
SDPP. There were no significant interactions of vaccin-
ation and starter diet on mortality rate during any
periods of the study. Female pigs had lower (P <0.01)
mortality rate d 14–48 (1.7 % vs 8.3 %), d 0–48 (2.2 % vs
8.3 %) and d 0–145 (3.8 % vs 11.1 %) compared to male
pigs (data not shown).
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Although the mortality rate was high, it was similar
to that of the source farm and was mainly consistent
with bacterial infections. Approximately 70 % of the
mortality occurred between d 14 and 48 after pigs
were fed a common diet without SDPP, but before
challenge with PCV2 inoculum at d 63. Nearly all
mortality cases during d 48 to 145 were described as
chronic bacterial infections associated with tail-biting
or due to euthanasia because of hind limb paralysis.
Necropsies were performed when feasible, but in some
cases it was not possible due to the advanced autolysis state
of the body. Most deaths were compatible with systemic
bacterial infections showing fibrinous polyserositis and
arthritis and, less frequently, colisepticemia-like diarrhea
and enteritis. A proportion of animals had a chronic course
displaying weight loss; those that died showed fibrous poly-
serositis and pericarditis, craneo-ventral pulmonary con-
solidation and/or arthritis. Infections by Haemophilus
parasuis, Mycoplasma hyorhinis and Escherichia coli could
have been involved together with other agents, but specific
laboratory investigations were not performed.
The source farm of the herd was sero-positive for
PRRSV, and circulation of this virus could potentially
have been a predisposing factor for subsequent bacterial
infections. However, IDDEX ELISA results for 100 sam-
ples taken at d 146 of the study indicated low (12 %)
prevalence of samples sero-positive for PRRSV, suggest-
ing PRRSV had not been circulating earlier in the study.
The experimental starter diets and all other diets
were non-medicated with the exception of the common
transition diet fed from d 48 to 58 when pigs were
moved from the nursery to the pre-fattening facility.
This diet contained 200 ppm amoxicillin, 24 ppm
oxbendazol, and 120 ppm colistin.
Pigs were monitored daily by visual inspection and ani-
mal caretakers applied prescribed treatments after veterin-
arian clinical inspection. Individual pig treatment for
polyserositis, arthritis and pneumonia included a prod-
uct based on Bencylpeniciline procaine 200,000 UI,
dihydrostreptomycin (sulfate) 200 mg and dexametha-
sone (sodium phosphate) 0.5 mg at the recommended
dose according to body weight. The percentage of pigs
given individual medications (ranged from 9.9 to
16.6 % across treatment groups) was not significantly
different for the various treatment group comparisons.
At d 26 of the study when several cases of arthritis
appeared, Amoxicillin (trihydrate) 70 % at 0.3 g/L was
added to drinking water for 5 days.
Individual pig BW
Results of individual pig BW data by day of experiment
from wean to finish (Table 2) indicated that pigs fed the
starter diet with SDPP had heavier average BW at d 7,
14 and 21 compared to pigs fed the control diet. How-
ever, at all other time periods there were no significant
differences due to the main effect of starter diet. Also
Table 1 Nursery performance of vaccinated pigs fed starter diet with porcine plasmaa
Treatment group Probability F-test
Variable Dayb 1 VC 2 VP 3 SC 4 SP SEM Trt Vac Diet VxD
ADG, g 0–7 57.6 105.8 70.0 104.4 6.57 <0.01 0.41 <0.01 0.31
ADFI, g 0–7 83.1 111.6 86.9 107.0 4.77 <0.01 0.94 <0.01 0.38
GF 0–7 0.730 0.941 0.805 0.965 0.063 <0.01 0.34 <0.01 0.64
ADG, g 7–14 176.9 180.9 183.4 189.1 8.47 0.77 0.39 0.57 0.92
ADFI, g 7–14 222.2 245.6 223.9 249.3 9.10 0.08 0.76 0.01 0.91
GF 7–14 0.812 0.742 0.811 0.761 0.029 0.22 0.76 0.04 0.73
ADG, g 0–14 117.3 143.3 126.7 146.8 5.28 <0.01 0.23 <0.01 0.58
ADFI, g 0–14 152.7 178.6 155.4 178.2 5.67 <0.01 0.84 <0.01 0.78
GF 0–14 0.763 0.804 0.812 0.827 0.024 0.27 0.14 0.24 0.57
ADG, g 14–48 440.8 448.4 449.8 433.8 8.95 0.57 0.75 0.64 0.20
ADFI, g 14–48 651.9 656.1 650.6 647.0 13.5 0.97 0.70 0.98 0.78
GF 14–48 0.678 0.684 0.694 0.672 0.009 0.39 0.82 0.37 0.14
ADG, g 0–48 346.4 359.4 355.5 350.1 6.83 0.55 0.99 0.58 0.19
ADFI, g 0–48 506.3 516.8 506.2 510.3 10.5 0.87 0.75 0.48 0.76
GF 0–48 0.687 0.696 0.705 0.688 0.009 0.45 0.59 0.67 0.14
aValues are least squares mean of the pen average performance variable analyzed for block and treatment group (Trt) using orthogonal treatment comparisons
for the effect of vaccination (Vac), starter diet (Diet) and interaction of vaccination and starter diet (VxD). Initial BW (5.83 ± 0.1 kg) was included as a covariant.
Starter diets were fed for the initial 14 d after weaning, and then all pigs were fed common diets from d 14 to 48. There were 13 pens per treatment group.
Treatment groups were a single injection at d 3 post-weaning with PCV2/MHYO vaccine (V) or saline (S) and starter diet with 0 % (C) or 6 % spray dried porcine
plasma (P)
bDay or period of experiment
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treatment comparisons for the main effect of vaccin-
ation or interaction of starter diet and vaccination
were not significant at any time periods of the study.
Significant effects for sex (data not shown) indicated
female pigs were heavier (P <0.03) than male pigs at
d 7 (6.51 vs 6.35 kg), d 14 (7.84 vs 7.58 kg) and d 35
(15.67 vs 15.13 kg); but by d 145, males (102.1 kg)
were heavier (P <0.01) than females (99.1 kg).
Carcass results
Due to mortality of 27 pigs, lost carcass identification of
36 pigs, and culling or rejection of eight pigs at slaugh-
ter, only 292 of the original 363 pigs started on the
experiment were used for carcass data (Table 2). Of the
eight pigs that were culled at the abattoir, four pigs were
culled due to hernias and the other four were culled due
to low BW.
There were no significant interactions for the effects
of starter diet by vaccination status for any of the carcass
parameters. The treatment comparison for the main
effect of starter diet indicated that pigs fed the SDPP diet
had heavier average carcass weight and average BW at d
145 for pigs that were classified at slaughter compared
to the groups fed the control starter diet. Vaccinated
pigs had heavier carcass weight and average BW at d
145 for pigs classified at slaughter compared to non-
vaccinated pigs. Carcass lean percentage was not signifi-
cant for the treatment comparisons of the main effects
for vaccination or starter diet. Also males had heavier d
145 BW of pigs classified at slaughter (103.1 kg vs
100.1 kg), heavier carcass weight (87.7 kg vs 85.3 kg),
and higher carcass lean percentage (58.2 % vs 57.3 %)
compared to females (data not shown).
ELISA values and genome results for PCV2
ELISA results for PCV2 S/P ratio and percentage of
sero-positive samples by treatment group and day of
experiment are presented in Fig. 1. The S/P results >17
were considered positive. The treatment comparisons
for the main effect of starter diet or interaction of starter
Table 2 Mortality, BW and carcass data of vaccinated pigs fed starter diets with porcine plasmaa
Treatment group Probability F-test
Variable Dayb 1 VC 2 VP 3 SC 4 SP SEM Trt Vac Diet VxD
Pigs, n 0 91 91 91 90 – – – – –
Mortality, % 0–14 1.09 0.00 0.00 0.00 0.55 0.41 0.32 0.32 0.32
14–48 8.89 4.37 5.53 1.11 2.26 0.11 0.14 0.05 0.98
0–48 9.95 4.37 5.53 1.11 2.32 0.06 0.10 0.03 0.80
48–145 1.32 0.00 4.77 3.36 1.66 0.17 0.03 0.40 0.98
0–145 11.06 4.37 9.95 4.44 2.74 0.17 0.85 0.03 0.82
BW, kg 0 5.84 5.83 5.82 5.84 0.10 0.99 0.96 0.97 0.89
7 6.24 6.58 6.32 6.57 0.06 <0.01 0.52 <0.01 0.44
14 7.49 7.84 7.60 7.90 0.09 <0.01 0.36 <0.01 0.73
21 9.17 9.62 9.53 9.66 0.14 0.06 0.15 0.04 0.27
35 15.06 15.64 15.39 15.55 0.25 0.38 0.62 0.22 0.57
48 22.47 23.14 22.90 22.70 0.44 0.63 0.98 0.53 0.24
63 33.32 34.56 34.90 34.09 0.54 0.46 0.84 0.22 0.29
83 49.64 50.48 49.46 49.92 0.73 0.76 0.60 0.36 0.79
114 73.40 75.20 72.22 72.14 1.12 0.16 0.06 0.44 0.39
145 100.7 102.3 98.67 100.8 1.20 0.18 0.13 0.11 0.83
Carcass, nc 159 70 74 72 76 – – – – –
BW, kgd 145 101.7 104.2 98.60 101.8 1.14 <0.01 0.01 0.01 0.77
Carcass, kg 159 86.43 88.70 84.05 86.90 0.94 <0.01 0.03 <0.01 0.75
Lean, % 159 57.97 57.38 58.00 57.48 0.36 0.47 0.85 0.11 0.92
aValues are least squares mean of percentage mortality, individual pig body weight (BW) and carcass variable by day or period of experiment analyzed for the effects of
sex (S), treatment group (Trt), and interaction of Trt and sex (TxS), using orthogonal treatment comparisons for the main effect of vaccination (Vac), starter diet (Diet)
and interaction of vaccination and starter diet (VxD). Initial BW (5.83 ± 0.1 kg) was included as a covariant. Starter diets were fed for the initial 14 d after weaning, and
then all pigs were fed common diets from d 14 to 145. Treatment factors were a single injection at d 3 post-weaning with PCV2/MHYO vaccine (V) or saline (S) and
starter diet with 0 % (C) or 6 % spray dried porcine plasma (P)
bDay or period of experiment
cNumber of carcasses classified at abattoir differed from number of pigs finished due to culling or lost carcass identification
dLive BW of pigs at d 145 that subsequently had carcasses classified on d 159
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diet and vaccination were not significant at any time
period for any of the ELISA results for PCV2. The main
effect of vaccination was significant for S/P ratio and
percentage sero-positivity for PCV2. Vaccinated pigs had
higher percentages of sero-positive samples at d 35, 63
and 78 compared to non-vaccinated pigs. Vaccinated
pigs had higher S/P ratio against PCV2 on d 35 and 63,
but lower S/P ratio on d 146 compared to non-
vaccinated pigs.
Percentage of sero-positive samples for PCV2 genome
(Fig. 2) was lower for vaccinated pigs at d 117 and 146
compared to non-vaccinated pigs, but no other signifi-
cant differences were detected at other days of the
experiment or for the main effect of starter diet or inter-
action of starter diet and vaccination.
ELISA values and genome results for MHYO
ELISA results for MHYO inhibition values and percentage
of sero-positive samples are presented in Fig. 3. MHYO
inhibition results >65 were interpreted as positive. There
were no significant effects of starter diet or interaction of
starter diet and vaccination on MHYO inhibition values
or percentage of sero-positive samples at any time periods.
Vaccinated pigs had higher MHYO inhibition value and
percentage of sero-positive samples at d 35, 63 and 78
compared to non-vaccinated pigs.
There were no significant effects of starter diet, vaccin-
ation, or interaction of diet and vaccination on PCR ana-
lysis of nasal swabs for MHYO genome at any time
period (Fig. 4). Nasal swabs were not sampled on days 0
and 35 of the study.
Discussion
Weaning of pigs is a period associated with multiple
stressors that contribute to reduced growth, feed intake,
and feed efficiency and increased morbidity and mortality
[18]. Reduced feed intake post-weaning is associated with
compromised intestinal barrier function [19]. Weaning
stress induces intestinal barrier dysfunctions associ-
ated with increased permeability and inflammation
that can impact present and future mucosal barrier
function [20–22].
Vaccines are useful for helping pigs develop resistance
to exposure to pathogens they encounter during their
lifetime. However, certain vaccines may stimulate an
immune response that results in a measurable reduction
of feed intake and growth [12]. When such a vaccine is
given around weaning time, this added stress may fur-
ther exacerbate the reduction in feed intake that is
already compromised by weaning stress.
Spray dried plasma has an important role in starter diets
as a functional protein source to provide nutrition to sup-
port pigs to better transition through the negative effects
of weaning stress. The beneficial effects of starter diets
containing spray dried plasma on post-weaning pig
growth, feed intake, and health are well known [1, 2].
Intestinal barrier dysfunctions associated with weaning
stress were reduced when pigs were provided starter diets
containing 5 % SDPP fed for 14 d after weaning compared
to 0 or 2.5 % SDPP, suggesting diets supplemented with
5 % SDPP support and maintain intestinal barrier function
[23]. Therefore, in the present study, 6 % SDPP was used
in the starter diet with the intention to assure adequate
Fig. 1 PCV2 ELISA results by treatment and day of experiment. Values are least squares means of treatment group by day of experiment for
serum S/P ratio (ratio, bars, left vertical scale) and percentage positive samples (% +, lines, right vertical scale) against PCV2 (26 samples per
treatment by day). S/P ratio >17 considered positive. Treatment groups were vaccinated (V) or saline (S) injected pigs on d 3 after weaning that
were fed starter diets with (P) or without (C) spray-dried porcine plasma for the initial 14 d post-weaning. One pig per pen was challenged with
PCV2 inoculum on d 63 after weaning. Data was analyzed for the effects of sex, treatment group and interaction of treatment group and sex
using orthogonal treatment comparisons for the main effects of vaccination (1 VC + 2 VP vs 3 SC + 4 SP), starter diet (1 VC + 3 SC vs 2 VP + 4 SP)
and interaction of vaccination and starter diet (1 VC + 4 SP vs 2 VP + 3 SC). ŧ Main effect of vaccination for day 35, 63 and 146 of the experiment
for S/P titer (P <0.05). *Main effect of vaccination for day 35, 63 and 78 of the experiment for % positive samples (P <0.05)
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SDPP was available to support intestinal barrier function
during this critical period of post-weaning stress.
In the present study, 6 % SDPP in the starter diet im-
proved short-term post-weaning growth, feed intake and
feed efficiency, regardless of vaccination status. Although
vaccination at d 3 post-weaning had no significant effect
on growth and feed intake, vaccinated pigs fed the con-
trol diet had the lowest daily weight gain, feed intake,
and gain to feed ratio suggesting a mild short-term effect
of the vaccination on growth and feed efficiency during
the initial week of the study.
The early growth advantage for pigs fed SDPP during
the initial 14 d after weaning was not maintained
through the end of the nursery phase (d 48), but by the
end of the study both vaccinated pigs and pigs fed
starter diet with SDPP had heavier BW and carcass
weight. Pigs previously fed SDPP in the starter diet had
reduced mortality to d 48 and this reduction of mortality
Fig. 2 Serum samples positive for PCV2 genome. Values are least squares means of treatment group by day of experiment for percentage of
serum samples positive for PCV2 genome (n = 26 samples per treatment by day). Treatment groups were vaccinated (V) or saline (S) injected pigs
on d 3 after weaning that were fed starter diets with (P) or without (C) spray-dried porcine plasma for the initial 14 d post-weaning. One pig per
pen was challenged with PCV2 inoculum on d 63 after weaning. Data was analyzed for the effects of sex, treatment group and interaction of
treatment group and sex using orthogonal treatment comparisons for the main effects of vaccination (1 VC + 2 VP vs 3 SC + 4 SP), starter diet
(1 VC + 3 SC vs 2 VP + 4 SP) and interaction of vaccination and starter diet (1 VC + 4 SP vs 2 VP + 3 SC). *Main effect of vaccination for day 117
and 146 of the experiment (P <0.05)
Fig. 3 MYHO ELISA results by treatment and day of experiment. Values are least squares means of treatment group by day of experiment for
serum inhibition titer (Inh%, bars, left vertical scale) and percentage positive samples (%+, lines, right vertical scale) against MHYO (26 samples per
treatment by day). Inhibition percentage >65 was considered positive. Treatment groups were vaccinated (V) or saline (S) injected pigs on d 3
after weaning that were fed starter diets with (P) or without (C) spray-dried porcine plasma for the initial 14 d post-weaning. One pig per pen
was challenged with PCV2 inoculum on d 63 after weaning. Data was analyzed for the effects of sex, treatment group and interaction of
treatment group and sex using orthogonal treatment comparisons for the main effects of vaccination (1 VC + 2 VP vs 3 SC + 4 SP), starter
diet (1 VC + 3 SC vs 2 VP + 4 SP) and interaction of vaccination and starter diet (1 VC + 4 SP vs 2 VP + 3 SC). *Main effect of vaccination
for day 35, 63, and 78 of the experiment (P <0.05) for both inhibition titer and percentage of positive samples
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was also maintained to the end of the study. Approxi-
mately 70 % of the mortality occurred between d 14 and
48 after pigs were fed a common diet without SDPP, and
most of this mortality was associated with lesions com-
patible with infection caused by Haemophilus parasuis,
Streptococcus suis or Mycoplasma hyorhinis or other
potential pathogens. Vaccinated pigs also had reduced
mortality from d 48 to 145. Nearly all mortality cases
during d 48 to 145 were described as chronic bacterial
infections associated with tail-biting or due to euthan-
asia because of hind limb paralysis.
Past studies have reported reduced mortality associated
with PCV2-SD afflicted nursery and grower pigs fed diets
with SDPP [3, 4], and this reduced mortality was extended
well beyond the feeding period of diets with SDPP [3].
Also, reduced lung lesions have been reported in pigs
fed diets with SDPP and experimentally-infected with
swine influenza virus [24]. Furthermore, intestinal
permeability of pigs previously fed a diet with 5 %
SDPP for 14 d post-weaning was reduced when sub-
sequently challenged with Salmonella typhimurium
and fed diets without SDPP [25]. Collectively, these
past results suggest SDPP in starter diets has a
longer-term impact on animal resilience to subse-
quent stress, and this may be related to the reduction
of intestinal barrier dysfunction associated with early
life stress.
Infectious pressure for PCV2 (Fig. 2) was <10 % for all
treatment groups up to d 63; but for MYHO genome
(Fig. 4), it was 18 to 26 % positive across treatment
groups at d 63. In order to increase the infectious pres-
sure for PCV2, one pig per pen was inoculated with
PCV2 at d 63. Serum PCV2 genome slowly progressed to
a higher percentage of positive samples (>50 %) for non-
vaccinated pigs by d 117; however, there was little increase
in serum PCV2 genome for vaccinated pigs, suggesting
vaccination helped reduce subsequent incidence of PCV2
viremia (Fig. 2).
Vaccination supported a strong PCV2 antibody response
(Fig. 1) and a modest MHYO antibody response (Fig. 3)
and these results are consistent with others [26–30]. A
high percentage of pigs at weaning (d 0) had antibodies to
PCV2 likely due to the ubiquitous nature of the virus and
its widespread sero-prevalence. Under normal conditions
pigs acquire antibodies via colostrum that may last up to
10 weeks of age. Therefore, the observed antibody values
for PCV2 at weaning are consistent with maternally
derived immunity.
Several factors may affect the seroconversion to
MHYO under field conditions, such as a variable pro-
portion of infected animals, elongated time to elicit an
immune response, or poor correlation of seroconversion
with protection that result in no differences in serocon-
version between vaccinated and non-vaccinated pigs
[31].
Vaccination also reduced the presence of PCV2
genome in serum, after the challenge with PCV2 and
this confirms previous research [32, 33]. These ser-
ology results may partially explain the reduced mor-
tality of vaccinated pigs during d 48 to 145 of the
study when pigs were challenged with PCV2. Starter
diet had no significant effects on antibody or genome
results. Under the conditions of this study, vaccin-
ation and feeding SDPP in the starter diet resulted in
Fig. 4 Nasal swab samples positive for MHYO genome. Values are least squares means of treatment group by day of experiment for percentage
of nasal swab samples positive for MHYO genome (n = 26 samples per treatment by day). Treatment groups were vaccinated (V) or saline (S) injected
pigs on d 3 after weaning that were fed starter diets with (P) or without (C) spray-dried porcine plasma for the initial 14 d post-weaning. One pig per
pen was challenged with PCV2 inoculum on d 63 after weaning. Data was analyzed for the effects of sex, treatment group and interaction of treatment
group and sex using orthogonal treatment comparisons for the main effects of vaccination (1 VC + 2 VP vs 3 SC + 4 SP), starter diet (1 VC + 3 SC vs 2
VP + 4 SP) and interaction of vaccination and starter diet (1 VC + 4 SP vs 2 VP + 3 SC). There were no significant differences detected among treatment
groups at any sampling time
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pigs with heavier final BW and carcass weight; how-
ever most of the reduced mortality was associated
with pigs fed the starter diet with SDPP.
Conclusions
Vaccination supported a long term antibody response
against PCV2 and a weaker antibody response against
MHYO for early finishing pigs challenged with PCV2.
SDPP in the starter diet along with vaccination supported
the best long-term beneficial effects on survival to market
and final BW and carcass weight. Both early life vaccin-
ation and nutrition supplemented with SDPP should be
considered for reducing risks of longer term mortality and
morbidity in later life stages.
Methods
Animals and housing
Pigs ([Large White × Landrace] × Pietrain) weaned at
21 ± 2 d of age were selected from a conventional
sow farm managed in a three-week batch farrowing
system and transported to an experimental farm at
IRTA. The sow farm was seropositive against PRRSV
at the time pigs were weaned. Pigs were assigned to 4
treatment groups (1 VC, 2 VP, 3 SC, 4 SP) in a 2 × 2
factorial arrangement of treatments with the effects of
injection at d 3 post-weaning with a PCV2/MHYO
combined vaccine (V) versus saline (S) or a starter
diet with 0 % (C) versus 6 % (P) SDPP as the primary
treatment factors. Maternal origin, sex, and weaning
weight were used as blocking factors, according to normal
procedures at IRTA. Sow parity was not directly used as a
blocking factor; however, parity was balanced across treat-
ment groups within block, since it was associated with
maternal origin as a blocking factor. After final allotment
there were 13 pens with six pens of males, six pens of
females, and one pen of mixed sex per treatment group.
There were seven pigs per pen, except one pen assigned
to treatment four (SP) had only six pigs for a total of 363
pigs started on experiment. Pigs were kept in two rooms
at the weaning facility for 48 d and individual pig BW and
feed data per pen were recorded at specific intervals
(Table 3). Each room had two rows of pens with a central
corridor (26 pens per room) with complete slatted floors
and pen dividers that allowed for direct pig contact
between pens. The experimental pigs were the only pigs
located at the weaning facility during the time of the
study. At d 48, the seven pigs from the original pens at the
weaning facility were moved as an intact group to a single
pen located in one of three different rooms in a grower
facility at the experimental farm and kept there until d 83.
The grower facility also had pen dividers that allowed
for direct pig contact between pens, however the
experimental pigs were the only pigs kept at the
grower facility during the time of the study. After day
83, pigs were moved again and finished at a commer-
cial farm until d 159 post-weaning before being trans-
ported to a commercial abattoir. The commercial
farm had no other pigs located at the finishing facility
Table 3 Schedule for data collection, sampling and other experimental events
Daya Pig age, d Pig weight Starter diet Vaccineb Challengec Blood sampled Nasal swabe
0 21 √ √ √
3 24 √ √
7 28 √ √
14 35 √ √
21 42 √
35 56 √ √
48f 69 √
63 84 √ √ √ √
78 99 √ √
83g 104 √
114 135 √
117 138 √ √
145 166 √
146h 167 √ √
aDay of experiment
bPigs were injected with either vaccine or saline
cOne pig per pen was inoculated intranasally with PCV2 culture
dBlood samples were collected from two pigs per pen for ELISA analysis for antibodies against PCV2 and MHYO and PCR for PCV2
eNasal swab samples were collected from two pigs per pen for PCR for MHYO
fAll pigs were moved from nursery to grower facility at IRTA on d 48
gAll pigs were moved from grower facility at IRTA to a commercial finishing farm d 83
hCarcass data was recorded d 159 for pigs classified at the abattoir
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during this time; however it was necessary to distrib-
ute pigs within treatment group into 10 to 12 pigs
per pen with all pens located in the same room. Pens
at the commercial finisher had solid pen dividers that
did not allow for pig contact between pens. From d
48 to 145 only individual pig body weight data was
recorded at specific intervals (Table 3). Carcass weight
and lean percentage classification was recorded at the
abattoir for 292 of the original 363 pigs started on
experiment. Experimental procedures for animals were
approved by the Departament de Medi Ambient i
Habitatge de la Generalitat de Catalunya.
Experimental starter diets
Two experimental non-medicated diets were fed during
the initial 14 d after weaning and were typical of com-
mercial starter diets for weaned pigs in Spain. SDPP was
included at 6 % of the test diet (P) and replaced soy pro-
tein concentrate used in the control diet (C) on an equal
lysine basis. Both starter diets were formulated to contain
1.45 % total lysine and met or exceeded nutrient require-
ments recommended by IRTA (Table 4). Common non-
medicated commercial diets by phase of production were
fed from d 14 to d 159 of the study to all pigs, with the
exception that the diet fed from d 48 to 58 of the study
contained 200 ppm amoxicillin, 24 ppm oxybendazol and
120 ppm colistin.
Vaccines
A combined PCV2 and MHYO vaccine was used by
mixing two vaccines Ingelvac-Circoflex™ and Ingelvac-
Mycoflex™ (Combo-Flex) prepared 1:1 according to the
manufacturer’s recommendations (Boehringer Ingelheim
Vetmedica GmbH, Ingelheim am Rhein, Germany). The
mixed vaccines were given as a single injection (2 ml) by
intramuscular route in the neck at d 3 post-weaning.
These vaccines were selected as the common prod-
ucts used under commercial conditions in the USA
and Europe. Non-vaccinated pigs were injected with
2 ml saline solution at d 3 post-weaning.
PCV2 inocula
Due to low infectious pressure of PCV2 at d 63 post
weaning (12 weeks of age), one pig in each pen was chal-
lenged with a field strain (SP-10-7-54-13) of PCV2b virus
(titer 105.24TCID50/ml) replicated in PK-15 cells free of
pestiviruses, Porcine circovirus type 1, and Torque teno sus
viruses 1 and 2 [34]. PCV2 was inoculated by intranasal
route by applying 1 ml of virus culture on each nostril
using an intranasal mucosal atomization device (LMA®
MAD300 nasal, Teleflex Medical, NC).
Sampling and analytical procedures
Blood samples and nasal swabs were collected from two
pigs per pen (104 total pigs; 28.7 % of all study pigs) at
selected intervals throughout the study (Table 3). The
same pigs were sampled throughout the experiment to
Table 4 Ingredient and calculated nutrient composition of
experimental starter diets
Ingredient, % Control Test
Barley 49.34 49.34
Wheat 1.58 0.00
Extruded whole soybeans 15.11 15.12
Soybean meal (47 % CP) 2.48 6.99
Spray dried porcine plasmaa 0.00 6.00
Soy protein concentrate 9.50 0.00
Dried sweet whey 13.72 13.72
Animal fat 5.24 6.09
Dicalcium phosphate 1.84 2.09
Calcium carbonate 0.00 0.04
Salt 0.28 0.00
Vitamin-trace mineral premixb 0.25 0.25
L-lysine 0.36 0.21
DL-methionine 0.19 0.15
L-threonine 0.11 0.02
Total, % 100.0 100.0
Calculated nutrients
Dry matter, % 89.97 89.55
Crude protein, % 21.08 21.08
Metabolizable energy, kcal/kg 3425 3425
Lactose, % 10.00 10.00
Ether extract, % 9.56 10.48
Ash, % 6.05 6.57
Calcium, % 0.73 0.80
Phosphorus, % 0.76 0.85
Digestible phosphorus, % 0.42 0.55
Sodium, % 0.22 0.34
Chloride, % 0.55 0.53
Lysine, % 1.45 1.45
Methionine, % 0.50 0.44
Methionine + Cysteine, % 0.87 0.89
Threonine, % 0.94 0.94
Tryptophan, % 0.26 0.29
aAP820™, APC Europe, Granollers, Spain
bProvided the following per kg of diet: vitamin A (E-672) 10000 UI; vitamin D3
(E-671) 2000 UI; vitamin E (alpha-tocopherol) 25 mg; vitamin B1 1.5 mg;
vitamin B2 3.5 mg; vitamin B6 2.4 mg; vitamin B12 20 μg; vitamin K3 1.5 mg;
calcium panthotenate 14 mg; nicotinic acid 20 mg; folic acid 0.5 mg; biotin
50 μg; Fe (E-1) (from FeSO4·H2O) 120 mg; I (E-2) (from Ca(I2O3)2) 0.75 mg; Co
(E-3) (from 2CoCO3·3Co(OH)2·H2O) 0.6 mg; Cu (E-4) (from CuSO4·5H2O) 150 mg;
Mn (E-5) (from MnO) 60 mg; Zn (E-6) (from ZnO) 110 mg; Se (E-8) (from
Na2SeO3) 0.37 mg
Pujols et al. Porcine Health Management  (2016) 2:4 Page 9 of 11
detect infection and seroconversion. A substitute pig from
the same pen was sampled if a previously sampled pig had
died. All blood by sampling day were centrifuged at 600 g
for 15 min at 4 °C and the serum was analyzed for MHYO
and PCV2 antibodies using respectively a monoclonal
blocking ELISA Oxoid™ Mycoplasma hyopneumoniae
(Oxoid LTD, UK) and an indirect ELISA Ingezim Circo
IgG 1.1 PCV.K1 (Ingenasa, Spain), following manufac-
turers’ instructions. The Oxoid™ ELISA detects antibodies
against the 74kD outer external protein of MHYO and is
considered more sensitive than and at least as specific as
other tests [35]. The Oxoid™ ELISA is less useful to meas-
ure antibody levels (it measures percentage of inhibition),
but in our study working with conventional pigs that may
have unspecific serum reactions for other Mycoplasma
species [36], the Oxoid™ ELISA kit was selected. For the
Oxoid™ ELISA test an inhibition value >65 was considered
positive, while for the PCV2 ELISA an S/P ratio >17 was
considered positive.
Nasal swabs were re-suspended in 1000 μL of sterile
phosphate-buffered saline (PBS) and vigorously vortexed,
and 200 μL of the suspension was used for MHYO DNA
extraction. DNA was extracted from nasal and serum
swab suspensions using BioSprint 96 DNA Blood Kit
(Quiagen Hilden, Germany) based on automated mag-
netic bead extraction system. To assess for potential
contamination during the extraction procedure a nega-
tive control was included using PBS as an extraction
substrate. Serum samples were analyzed for the presence
of PCV2 genome by means of a real time quantitative
PCR (qrt-PCR) as previously described [37]. Viral con-
centrations were expressed as PCV2 DNA copy numbers
per ml of serum, as described previously [38]. Nested
PCR (nPCR) for MHYO were tested by means of a pre-
viously described technique [31, 39].
Statistical analysis
Pen was used as the experimental unit when analyzing the
effect of weight block and treatment group. Orthogonal
treatment comparisons for the main effects of vaccination
(treatment groups 1 VC + 2 VP vs treatment groups 3
SC + 4 SP), starter diet (2 VP + 4 SP vs 1 VC + 3 SC),
and interaction of vaccination and starter diet (1 VC +
4 SP vs 2 VP + 3 SC), along with the covariance of ini-
tial BW were included in the analysis of variance model
(SAS 9.2, SAS Inst. Inc., Cary, NC). Individual pig BW
and mortality rate at various intervals from wean to finish
and individual pig carcass data were analyzed for treat-
ment group, sex, and interaction of treatment and sex,
along with the covariance of initial BW and the orthog-
onal treatment comparisons previously described. Ser-
ology and nasal swab data were analyzed the same as
individual pig body weight and carcass data. Results were
considered significant at P <0.05.
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